Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.8B | 1.7B | 1.8B | 1.7B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 26M | 27M | 28M | 30M |
Other income expense | — | — | — | — |
Pretax income | 126M | 55M | 161M | 143M |
Tax provision | 36M | 20M | 40M | 32M |
Net income | 85M | 30M | 118M | 110M |
Basic EPS | 0.1 | 0 | 0.2 | 0.2 |
Diluted EPS | 0.1 | 0 | 0.2 | 0.2 |
Basic average shares | 467.8M | 475.7M | 481.8M | 488.1M |
Diluted average shares | 473.0M | 482.0M | 487.4M | 492.9M |
EBITDA | — | — | — | — |
Net income from continuing op. | 90M | 35M | 121M | 111M |
Minority interests | -31M | -31M | -33M | -34M |
Preferred stock dividends | — | — | — | — |